Preparation and characterization of gelatin-based mucoadhesive nanocomposites as intravesical gene delivery scaffolds

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Liu, Ching Wen ^a   Chang, Li Ching ^b   Lin, Kai Jen ^b   Yu, Tsan Jung ^b   Tsai, Ching Chung ^a,b   Wang, Hao Kuang ^b   Tsai, Tong Rong ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GELATIN; GLUTARALDEHYDE; GREEN FLUORESCENT PROTEIN; NANOCOMPOSITE; NINHYDRIN; PRONASE; HYDROGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER COMPLIANCE; CONTROLLED STUDY; CROSS LINKING; CYSTOMETRY; ENZYME DEGRADATION; GENE DELIVERY SYSTEM; GENE TARGETING; HYDRATION; HYDROGEL; INTRAVESICAL DRUG ADMINISTRATION; LENTIVIRINAE; MUCOADHESION; NONHUMAN; PARTICLE SIZE; RAT; URODYNAMICS; UROTHELIUM; VISCOSITY; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; GENE TRANSFER; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; PATHOPHYSIOLOGY;

ANIMALS; GELATIN; GENE TRANSFER TECHNIQUES; GLUTARAL; HUMANS; HYDROGELS; LENTIVIRUS; NANOCOMPOSITES; RATS; UROTHELIUM;

EID: 84945228934     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/473823     Document Type: Article

References (32)

1. M. Babjuk, M. Burger, R. Zigeuner et al., "EAU guidelines on non-muscle-invasive Urothelial carcinoma of the bladder: update 2013, " EuropeanUrology, vol. 64, no. 4, pp.639-653, 2013.
2. P. Tyagi, P.-C.Wu, M. Chancellor, N.Yoshimura, and L. Huang, "Recent advances in intravesical drug/gene delivery, "Molecular Pharmaceutics, vol. 3, no. 4, pp. 369-379, 2006.
3. J.-P. Chen, Y.-L. Leu, C.-L. Fang, C.-H. Chen, and J.-Y. Fang, "Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin, " Journal of Pharmaceutical Sciences, vol. 100, no. 2, pp. 655-666, 2011.
4. A. O. Elzoghby, W.M. Samy, and N.A. Elgindy, "Protein-based nanocarriers as promising drug and gene delivery systems, " Journal of Controlled Release, vol. 161, no. 1, pp. 38-49, 2012.
5. J. A. Wieland, T. L. Houchin-Ray, and L. D. Shea, "Non-viral vector delivery from PEG-hyaluronic acid hydrogels, " Journal of Controlled Release, vol. 120, no. 3, pp. 233-241, 2007.
6. Q. Xing, K. Yates, C. Vogt, Z. Qian, M. C. Frost, and F. Zhao, "Increasingmechanical strength of gelatin hydrogels by divalent metal ion removal, " Scientific Reports, vol. 4, article4706, 2014.
7. P. Johns and A. Courts, "Relationship between collagen and gelatin, " in The Science and Technology of Gelatin, A. G. Ward and A. Courts, Eds., pp. 164-165, Academic Press, New York, NY, USA, 1977.
8. K. Zwiorek, J. Kloeckner, E. Wagner, and C. Coester, "Gelatin nanoparticles as a newand simple gene delivery system, " Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 4, pp. 22- 28, 2004.
9. B. Mohanty and H. B. Bohidar, "Microscopic structureof gelatin coacervates, " International Journal of Biological Macromolecules, vol. 36, no. 1-2, pp. 39-46, 2005.
10. E. Leo, M. A. Vandelli, R. Cameroni, and F. Forni, "Doxorubicin- loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process, " International Journal of Pharmaceutics, vol. 155, no. 1, pp. 75-82, 1997.
11. A. J. Kuijpers, G. H. M. Engbers, J. Feijen et al., "Characterization of the network structure of carbodiimide cross-linked gelatin gels, "Macromolecules, vol. 32, no. 10, pp. 3325-3333, 1999.
12. Z. Shen, T. Shen, M. G. Wientjes, M. A. O'Donnell, and J. L.-S. Au, "Intravesical treatments of bladder cancer: Review, " Pharmaceutical Research, vol. 25, no. 7, pp. 1500-1510, 2008.
13. P. Tyagi, Z. Li, M. Chancellor, W. C. De Groat, N. Yoshimura, and L. Huang, "Sustained intravesical drug delivery using thermosensitive hydrogel, " Pharmaceutical Research, vol. 21, no. 5, pp. 832-837, 2004.
14. J.-Y. Fang and Z.-R. Huang, "Intravesical drug delivery into the bladder to treat cancers, " Current Drug Delivery, vol. 6, no. 3, pp. 227-237, 2009.
15. S. K. Seidlits, R. M. Gower, J. A. Shepard, and L. D. Shea, "Hydrogels for lentiviral gene delivery, " Expert Opinion on Drug Delivery, vol. 10, no. 4, pp. 499-509, 2013.
16. L. Naldini, U. Blömer, P. Gallay et al., "In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, " Science, vol. 272, no. 5259, pp. 263-267, 1996.
17. H.W. Sung, D. M. Huang, W. H. Chang, R. N. Huang, and J.C. Hsu, "Evaluation of gelatin hydrogel crosslinked with various crosslinking agents as bioadhesives: in vitro study, " Journal of BiomedicalMaterials Research, vol. 46, no. 4, pp. 520-530, 1999.
18. L.-C. Chang, C.-L. Wu, C.-W. Liu, W.-H. Chuo, P.-C. Li, and T.-R. Tsai, "Preparation, characterization and cytotoxicity evaluation of tanshinone IIA nanoemulsions, " Journal of Biomedical Nanotechnology, vol. 7, no. 4, pp. 558-567, 2011.
19. S. Q. Liu, P. L. Rachelee, C. Y. Ke, J. L. Hedrick, and Y. Y. Yang, "Biodegradable poly(ethylene glycol)-peptide hydrogels with well-defined structure and properties for cell delivery, " Biomaterials, vol. 30, no. 8, pp. 1453-1461, 2009.
20. Z. Lu, T.-K. Yeh, M. Tsai, J. L.-S. Au, and M. G. Wientjes, "Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy, " Clinical Cancer Research, vol. 10, no. 22, pp. 7677-7684, 2004.
21. S. Prochazkova, K. M. Varum, and K. Ostgaard, "Quantitative determination of chitosans by ninhydrin, " Carbohydrate Polymers, vol. 38, no. 2, pp. 115-122, 1999.
22. S. Shin and L. D. Shea, "Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels, " MolecularTherapy, vol. 18, no. 4, pp. 700-706, 2010.
23. B. Zhang, P. Metharom, H. Jullie et al., "The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events, " Genetic Vaccines and Therapy, vol. 2, no. 1, pp. 6-15, 2004.
24. M. E. Kidd, S. Shin, and L. D. Shea, "Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo, " Journal of Controlled Release, vol. 157, no. 1, pp. 80-85, 2012.
25. S.-M. Chuang, K.-M. Liu, Y.-L. Li et al., "Dual involvements of cyclooxygenase and nitric oxide synthase expressions in ketamine-induced ulcerative cystitis in rat bladder, " Neurourology and Urodynamics, vol. 32, no. 8, pp. 1137-1143, 2013.
26. Y.-S. Juan, S.-M. Chuang, Y.-L. Lee et al., "Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model, " BJU International, vol. 110, no. 6, pp. E236-E244, 2012.
27. S.-J. Lee, S. W. Kim, H. Chung et al., "Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel, " Chemotherapy, vol. 51, no. 6, pp. 311-318, 2005.
28. Y. Zhang, H. Ouyang, T. L. Chwee, S. Ramakrishna, and Z.- M. Huang, "Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds, " Journal of Biomedical Materials Research-Part B Applied Biomaterials, vol. 72, no. 1, pp. 156- 165, 2005.
29. W. H. Foresman and E. M. Messing, "Bladder cancer: natural history, tumor markers, and early detection strategies, " Seminars in Surgical Oncology, vol. 13, no. 5, pp. 299-306, 1997.
30. M. Wood, P. Perrotte, E. Onishi et al., "Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse, " Cancer GeneTherapy, vol. 6, no. 4, pp. 367-372, 1999.
31. L. J. Chang and E. E. Gay, "The molecular genetics of lentiviral vectors-current and future perspectives, " Current Gene Therapy, vol. 1, no. 3, pp. 237-251, 2001.
32. + progenitor cells, "Molecular Therapy, vol. 8, no. 6, pp. 981-991, 2003.